Contribute Try STAT+ Today

WASHINGTON — A federal judge on Monday blocked a Trump administration regulation that requires drug makers to include their sticker prices in ads.

The decision, which came just hours before the rule was set to take effect at midnight on Wednesday, came after three major drug makers sued the administration in June, arguing the Department of Health and Human Services did not have the authority to require these disclosures and that requiring them violated the drug makers’ First Amendment rights.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • How could they comply. There is no one price. There’s a price for you and a price for me and a price for those folks over there.

Comments are closed.

Your daily dose of news in health and medicine

Privacy Policy